Northern Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503M | Sell |
|
|||||
|
2025
Q1 | $635M | Sell |
|
|||||
|
2024
Q4 | $751M | Buy |
|
|||||
|
2024
Q3 | $966M | Sell |
|
|||||
|
2024
Q2 | $1.02B | Sell |
|
|||||
|
2024
Q1 | $954M | Sell |
|
|||||
|
2023
Q4 | $919M | Sell |
|
|||||
|
2023
Q3 | $878M | Buy |
|
|||||
|
2023
Q2 | $742M | Sell |
|
|||||
|
2023
Q1 | $949M | Sell |
|
|||||
|
2022
Q4 | $840M | Sell |
|
|||||
|
2022
Q3 | $819M | Sell |
|
|||||
|
2022
Q2 | $709M | Sell |
|
|||||
|
2022
Q1 | $839M | Sell |
|
|||||
|
2021
Q4 | $760M | Buy |
|
|||||
|
2021
Q3 | $726M | Buy |
|
|||||
|
2021
Q2 | $649M | Sell |
|
|||||
|
2021
Q1 | $557M | Sell |
|
|||||
|
2020
Q4 | $600M | Sell |
|
|||||
|
2020
Q3 | $720M | Buy |
|
|||||
|
2020
Q2 | $764M | Buy |
|
|||||
|
2020
Q1 | $469M | Buy |
|
|||||
|
2019
Q4 | $355M | Buy |
|
|||||
|
2019
Q3 | $261M | Sell |
|
|||||
|
2019
Q2 | $306M | Buy |
|
|||||
|
2019
Q1 | $400M | Buy |
|
|||||
|
2018
Q4 | $356M | Buy |
|
|||||
|
2018
Q3 | $376M | Sell |
|
|||||
|
2018
Q2 | $322M | Buy |
|
|||||
|
2018
Q1 | $316M | Sell |
|
|||||
|
2017
Q4 | $352M | Sell |
|
|||||
|
2017
Q3 | $428M | Buy |
|
|||||
|
2017
Q2 | $457M | Buy |
|
|||||
|
2017
Q1 | $358M | Buy |
|
|||||
|
2016
Q4 | $328M | Sell |
|
|||||
|
2016
Q3 | $371M | Buy |
|
|||||
|
2016
Q2 | $323M | Sell |
|
|||||
|
2016
Q1 | $338M | Sell |
|
|||||
|
2015
Q4 | $503M | Sell |
|
|||||
|
2015
Q3 | $449M | Sell |
|
|||||
|
2015
Q2 | $505M | Buy |
|
|||||
|
2015
Q1 | $418M | Sell |
|
|||||
|
2014
Q4 | $390M | Sell |
|
|||||
|
2014
Q3 | $347M | Sell |
|
|||||
|
2014
Q2 | $288M | Sell |
|
|||||
|
2014
Q1 | $319M | Buy |
|
|||||
|
2013
Q4 | $288M | Buy |
|
|||||
|
2013
Q3 | $314M | Sell |
|
|||||
|
2013
Q2 | $228M | Buy |
|